Company

Insulin glargine (CAS 160337-95-1) is a long-acting basal insulin analogue, helping control the blood sugar level of those with type 1 and type 2 diabetes mellitus. It is an analogue of human insulin made by replacing the asparagine residue at position A21 of the A-chain with glycine and adding two arginines to the C-terminus (positions B31 and 32) of the B-chain. Right now, insulin glargine (CAS 160337-95-1) API is commercially available . We are working on its international registration, such as DMF/ CEP/ J-DMF and so on. If you need insulin glargine API with DMF USP grade (CAS 160337-95-1), please kindly contact us via following contact information., Insulin, Insulin glargine

Cetuximab is an epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions. Both the finished product of Cetuximab and bulk solution can be supplied commercially!, Cetuximab, Anti cancer

Lysergol is applicated as Intermediate of Cabergoline and Nicergoline..etc.Material is produced in US FDA and EDQM approved factory., Intermediate, Cabergoline, Nicergoline

9,10-Dihydrolysergol is applicated as Intermediate of Cabergoline and Nicergoline..etc.Material is produced in US FDA and EDQM approved factory., Intermediate, Cabergoline, Nicergoline

9,10-Dihydrolysergic acid is applicated as Intermediate of Cabergoline and Nicergoline..etc.Material is produced in US FDA and EDQM approved factory., Intermediate, Cabergoline, Nicergoline